Literature DB >> 145549

Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies.

H H Goebel, R Heipertz, W Scholz, K Iqbal, I Tellez-Nagel.   

Abstract

A brain biopsy from a 20-year-old patient whose clinical course was marked by progressive dementia and chorea since age 10 years showed increased amounts of lipofuscin, abnormal mitochondria, and other organelles in cortical neurons, neurites, and astrocytes. Juvenile Huntington chorea was confirmed at autopsy. High levels of three histone-like proteins (molecular weight 10,000 to 16,000) in the microsomal fraction of purified neurons were found by SDS-polyacrylamide gel electrophoresis. Fatty acids were abnormal in white matter sphingomyelin. These ultrastructural and biochemical findings conformed to those established in adult Huntington chorea, thus strengthening the concept of a uniform pathologic process in adult and juvenile Huntington diseases in spite of some clinical and histologic differences.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 145549     DOI: 10.1212/wnl.28.1.23

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

Review 1.  Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration.

Authors:  Jorge M A Oliveira
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

2.  The ultrastructural variability of non-specific lipopigments.

Authors:  H H Goebel; F Schulz
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

Review 3.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

4.  Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.

Authors:  L Harms; H Meierkord; G Timm; L Pfeiffer; A C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 5.  Shaping the role of mitochondria in the pathogenesis of Huntington's disease.

Authors:  Veronica Costa; Luca Scorrano
Journal:  EMBO J       Date:  2012-03-23       Impact factor: 11.598

6.  Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.

Authors:  Ana María Estrada-Sánchez; George V Rebec
Journal:  Basal Ganglia       Date:  2012-07-01

7.  Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.

Authors:  Janett Eckmann; Laura E Clemens; Schamim H Eckert; Stephanie Hagl; Libo Yu-Taeger; Thierry Bordet; Rebecca M Pruss; Walter E Muller; Kristina Leuner; Huu P Nguyen; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-03-18       Impact factor: 5.590

Review 8.  Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Authors:  Alessandro Prinetti; Simona Prioni; Elena Chiricozzi; Edward H Schuchman; Vanna Chigorno; Sandro Sonnino
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

9.  Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.

Authors:  Shuqiu Zheng; Erin B D Clabough; Sovan Sarkar; Marie Futter; David C Rubinsztein; Scott O Zeitlin
Journal:  PLoS Genet       Date:  2010-02-05       Impact factor: 5.917

Review 10.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Authors:  Rodrigo A Quintanilla; Gail V W Johnson
Journal:  Brain Res Bull       Date:  2009-07-19       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.